Letter by Hjuler et al Regarding Article, “Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
Lerman et al1 report the increased presence of noncalcified coronary plaques and high-risk plaques in patients with psoriasis in comparison with healthy volunteers and a separately and previously included older at-risk population of hyperlipidemic patients. They concluded that modulation of skin inflammation was associated with a reduced coronary plaque burden.
These findings corroborate previous studies showing increased prevalence of coronary artery disease in patients with psoriasis2 and reduced coronary artery disease progression in patients with psoriasis treated with biological agents.3 The results of Lerman et al are in line with a previous report of reduced progression of noncalcified coronary vessel wall volume in patients with psoriasis treated with biological agents.3 However, these studies were performed in patients …